The certification enables the reagent maker to create optimizing products for use beyond the research market.
CBC also recently achieved ISO DIN/EN 17025:2005 accreditation for the extraction of total RNA from body fluids and the analysis of microRNA and mRNA.
The Center for Human Genetics and Laboratory Medicine's Prenatalis test is based on Illumina's Verifi technology.
The recertification covers design, production, and sale of the firm's qNPA technology-based gene expression analysis products and services.
The company achieved ISO 13485 certification for two facilities, extending their capabilities to manufacture and offer raw materials used in diagnostic assays.
The certification covers the development, production, and distribution of in vitro diagnostics for autoimmune disease.
The test uses mitochondrial DNA hybridization arrays to detect up to 21 animals that are ingredients or contaminants in food for humans, pets, and livestock.
The New Zealand-based cancer diagnostics firm received ISO 15189:2012 accreditation.
The certification follows CLIA certification and CAP accreditation for the firm's Cambridge, Mass. next-generation sequencing laboratory.
The accreditation is for Illumina-based sequencing services and covers HiSeq and MiSeq sequencing, RNA and DNA library preparation, and other services.
The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.
In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.
The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.
In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.